Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Asha Tanna"'
Publikováno v:
Journal of Medical Microbiology. 55:1419-1423
Currently there are 93 validated M serotypes of Streptococcus pyogenes, Lancefield group A streptococcus (GAS), and >130 emm genotypes. A marked increase in the number of non-typable GAS isolates (2 % in 2000, 4 % in 2001 and 9 % in 2002) from invasi
Autor:
Asha Tanna, Edouard Bingen, Robert M. Cohen, Chawki Loukil, Frederic Fitoussi, Dominique Deforche, Rob George, Isabelle Le Thomas, Catherine Doit, Naima Brahimi
Publikováno v:
Antimicrobial Agents and Chemotherapy. 44:1453-1457
A total of 1,500 recent throat isolates of Streptococcus pyogenes collected between 1996 and 1999 from children throughout France were tested for their susceptibility to erythromycin, azithromycin, josamycin, clindamycin, and streptogramin B. The ery
Publikováno v:
Journal of Clinical Microbiology. 36:3133-3137
Fluorescent amplified-fragment length polymorphism (FAFLP) analysis was carried out for an outbreak of group A streptococcal (GAS) invasive disease. Streptococcal genomic DNAs were digested with endonucleases Eco RI and Mse I, site-specific adaptors
Publikováno v:
Journal of Infectious Diseases. 174:500-506
Streptococcus pyogenes strains were genotyped by a combination of molecular methods for high- resolution epidemiologic studies of disease outbreaks. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis of the emm gen
Publikováno v:
Journal of Medical Microbiology. 39:165-178
A total of 16,909 cultures of Streptococcus pyogenes (Lancefield group A) isolated in Britain during 1980-90 were examined for T- and M-protein antigens. One or other M antigen was detected in 92.6% of the strains. The numbers of isolates of some ser
Autor:
Maria Koliou, Asha Tanna, Claes Schalén, Panayotis T. Tassios, Tuula Siljander, Lenka Strakova, Kim Ekelund, Bogdan Luca-Harari, Aftab Jasir, Birgitta Henriques-Normark, Roberta Creti, Androulla Efstratiou, Shona Neal, Jessica Darenberg, Monica Straut, Mark van der Linden, Jaana Vuopio-Varkila, Anne Bouvet
Publikováno v:
Journal of Clinical Microbiology; 47, pp 1155-1165 (2009)
In an attempt to compare the epidemiology of severeStreptococcus pyogenesinfection within Europe, prospective data were collected through the Strep-EURO program. Surveillance for severe cases ofS. pyogenesinfection diagnosed during 2003 and 2004 was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e5924cb582cc0268ef542a50ac6aba8
http://lup.lub.lu.se/record/1289432/file/1314631.pdf
http://lup.lub.lu.se/record/1289432/file/1314631.pdf
Autor:
John Paul, Marc Cubbon, Stephanie J. Curtis, Androulla Efstratiou, Shiranee Sriskandan, Asha Tanna, Hugh H. Russell
Publikováno v:
The Journal of infection. 54(5)
Summary Objectives Injecting drug users (IDU) represent an increasing proportion of patients with invasive group A streptococcal (GAS) disease. Our aims were to characterise the clinical presentation and strains causing GAS bacteremia in IDU from a s
Autor:
Androulla Efstratiou, Michaela Emery, Robert George, Asha Tanna, Theresa Lamagni, Marina Warner
Publikováno v:
Journal of medical microbiology. 52(Pt 6)
During 2000, the UK witnessed a sudden increase in severe infections and related deaths in injecting drug users (IDUs), sparking off a UK-wide investigation. A worrying upward trend in severe group A streptococcal (GAS) infections has recently been o
Publikováno v:
Journal of clinical microbiology. 39(2)
For many years group A streptococci of T type 28 (T28) have been common in southern Sweden; however, since 1995 resistance to both macrolide-lincosamide-streptogramin B (MLS) antibiotics and tetracycline was observed among T28 isolates, which prompte
Streptococcus pyogenes , a major human pathogen, is still considered susceptible to beta-lactams, but for other relevant antibiotics, highly variable resistance rates have been reported. Since no data were available from Iran, we tested 1,335 throat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c927ee794884bfddb3e3c4af38cfe1e9
https://europepmc.org/articles/PMC86737/
https://europepmc.org/articles/PMC86737/